Article
Microdissection-based genotyping assists discrimination of reactive gliosis from glioma.
American journal of clinical pathology - 1 May 2004
Finkelstein Sydney D, Mohan Deepak, Hamilton Ronald L, Sasatomi Eizaburo, Swalsky Patricia A, Lieberman Frank S
Abstract excerpt
We used molecular anatomic pathology to determine the mutational status (loss of heterozygosity [LOH]) to make the distinction between reactive gliosis and glial neoplasia. LOH has been shown to be absent in reactive states and present in neoplastic cellular proliferations. Three groups of patient specimens were analyzed: group 1, reactive gliosis (n = 15); group 2, gliomas of varying histologic type and grade (n...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
